520 related articles for article (PubMed ID: 17204316)
21. Plasma tissue factor antigen in localized prostate cancer: distribution, clinical significance and correlation with haemostatic activation markers.
Langer F; Chun FK; Amirkhosravi A; Friedrich M; Leuenroth S; Eifrig B; Bokemeyer C; Francis JL
Thromb Haemost; 2007 Mar; 97(3):464-70. PubMed ID: 17334515
[TBL] [Abstract][Full Text] [Related]
22. Activation of coagulation, anti-coagulation, fibrinolysis and the complement system in patients with urticaria.
Zhu H; Liang B; Li R; Li J; Lin L; Ma S; Wang J
Asian Pac J Allergy Immunol; 2013 Mar; 31(1):43-50. PubMed ID: 23517393
[TBL] [Abstract][Full Text] [Related]
23. Activation of coagulation in chronic urticaria in relation to disease severity and activity.
Farres MN; Refaat M; Melek NA; Ahmed EE; Shamseldine MG; Arafa NA
Allergol Immunopathol (Madr); 2015; 43(2):162-7. PubMed ID: 25088671
[TBL] [Abstract][Full Text] [Related]
24. Endothelial cell activation and blood coagulation in critically ill patients with lung injury.
Wenzel C; Kofler J; Locker GJ; Laczika K; Quehenberger P; Frass M; Knöbl P
Wien Klin Wochenschr; 2002 Oct; 114(19-20):853-8. PubMed ID: 12503477
[TBL] [Abstract][Full Text] [Related]
25. Antihistamines do not inhibit the flare induced by the intradermal injection of autologous plasma in chronic urticaria patients.
Asero R; Tedeschi A; Lorini M; Cugno M
Eur Ann Allergy Clin Immunol; 2009 Dec; 41(6):181-6. PubMed ID: 20128232
[TBL] [Abstract][Full Text] [Related]
26. Coagulation and fibrinolysis factors in dialysis patients with and without ischemic heart disease.
Oda H; Ohno M; Ohashi H
Adv Perit Dial; 2000; 16():152-5. PubMed ID: 11045282
[TBL] [Abstract][Full Text] [Related]
27. Monitoring high-dose heparinization during cardiopulmonary by-pass--a comparison between prothrombinase-induced clotting time (PiCT) and two chromogenic anti-factor Xa activity assays.
Raivio P; Kuitunen A; Petäjä J; Ilveskero S; Lassila R
Thromb Haemost; 2008 Feb; 99(2):427-34. PubMed ID: 18278195
[TBL] [Abstract][Full Text] [Related]
28. Plasma tissue factor and tissue factor pathway inhibitor in patients with primary glomerulonephritis.
Lizakowski S; Zdrojewski Z; Jagodzinski P; Rutkowski B
Scand J Urol Nephrol; 2007; 41(3):237-42. PubMed ID: 17469034
[TBL] [Abstract][Full Text] [Related]
29. Correlation between tumor necrosis factor-alpha and D-dimer levels in non-small cell lung cancer patients.
Guadagni F; Ferroni P; Basili S; Facciolo F; Carlini S; Crecco M; Martini F; Spila A; D'Alessandro R; Aloe S; Cerasoli V; Del Monte G; Mariotti S; Mineo TC; Roselli M
Lung Cancer; 2004 Jun; 44(3):303-10. PubMed ID: 15140543
[TBL] [Abstract][Full Text] [Related]
30. Haemostatic complications in haemodialysis patients: effect of type of vascular access and dialysis filter.
Yu A; Egberg N; Jacobson SH
Scand J Clin Lab Invest; 2003; 63(2):127-33. PubMed ID: 12751694
[TBL] [Abstract][Full Text] [Related]
31. Plasma levels of prothrombin fragment F1+2, D-dimer and prothrombin time correlate with clinical stage and lymph node metastasis in operable gastric cancer patients.
Kwon HC; Oh SY; Lee S; Kim SH; Han JY; Koh RY; Kim MC; Kim HJ
Jpn J Clin Oncol; 2008 Jan; 38(1):2-7. PubMed ID: 18258711
[TBL] [Abstract][Full Text] [Related]
32. Platelet (dys)function and plasma plasminogen levels in hemodialysis patients.
Salobir B; Sabovic M; Zupan IP; Ponikvar JB
Ther Apher Dial; 2008 Apr; 12(2):133-6. PubMed ID: 18387161
[TBL] [Abstract][Full Text] [Related]
33. [Changing characteristic of blood coagulation factors and their correlation with blood coagulation status in different hepatic diseases].
Chen J; Duan ZP; Bai L; Zhao J; Ding M; Tong XY; Cong YL
Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):206-10. PubMed ID: 22475141
[TBL] [Abstract][Full Text] [Related]
34. Increased plasma levels of matrix metalloproteinase-9 are associated with the severity of chronic urticaria.
Kessel A; Bishara R; Amital A; Bamberger E; Sabo E; Grushko G; Toubi E
Clin Exp Allergy; 2005 Feb; 35(2):221-5. PubMed ID: 15725195
[TBL] [Abstract][Full Text] [Related]
35. Hypercoagulability is independently associated with kynurenine pathway activation in dialysed uraemic patients.
Pawlak K; Mysliwiec M; Pawlak D
Thromb Haemost; 2009 Jul; 102(1):49-55. PubMed ID: 19572067
[TBL] [Abstract][Full Text] [Related]
36. Activation of coagulation and fibrinolysis in childhood diarrhoea-associated haemolytic uraemic syndrome.
Nevard CH; Jurd KM; Lane DA; Philippou H; Haycock GB; Hunt BJ
Thromb Haemost; 1997 Dec; 78(6):1450-5. PubMed ID: 9423793
[TBL] [Abstract][Full Text] [Related]
37. Another point of view on the mechanism of thrombin generation during cardiopulmonary bypass: role of tissue factor pathway inhibitor.
Kojima T; Gando S; Kemmotsu O; Mashio H; Goda Y; Kawahigashi H; Watanabe N
J Cardiothorac Vasc Anesth; 2001 Feb; 15(1):60-4. PubMed ID: 11254842
[TBL] [Abstract][Full Text] [Related]
38. Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: observations from the ESTEEM Trial.
Christersson C; Oldgren J; Bylock A; Siegbahn A; Wallentin L
Eur Heart J; 2007 Mar; 28(6):692-8. PubMed ID: 17314111
[TBL] [Abstract][Full Text] [Related]
39. Quantitative and temporal differences in coagulation, fibrinolysis and platelet activation after on-pump and off-pump coronary artery bypass surgery.
Vallely MP; Bannon PG; Bayfield MS; Hughes CF; Kritharides L
Heart Lung Circ; 2009 Apr; 18(2):123-30. PubMed ID: 19081297
[TBL] [Abstract][Full Text] [Related]
40. Activation of Blood Coagulation in Two Prototypic Autoimmune Skin Diseases: A Possible Link with Thrombotic Risk.
Cugno M; Tedeschi A; Borghi A; Bucciarelli P; Asero R; Venegoni L; Griffini S; Grovetti E; Berti E; Marzano AV
PLoS One; 2015; 10(6):e0129456. PubMed ID: 26057532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
